Moderna, Inc. (FRA:0QF)
21.89
+0.86 (4.07%)
Oct 1, 2025, 11:05 AM CET
Moderna Revenue
Moderna had revenue of $142.00M USD in the quarter ending June 30, 2025, a decrease of -41.08%. This brings the company's revenue in the last twelve months to $3.08B, down -39.05% year-over-year. In the year 2024, Moderna had annual revenue of $3.24B, down -52.75%.
Revenue (ttm)
$3.08B
Revenue Growth
-39.05%
P/S Ratio
3.27
Revenue / Employee
$530.69K
Employees
5,800
Market Cap
8.57B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.40B |
Carl Zeiss Meditec AG | 2.18B |
Moderna News
- 1 day ago - 3 Of My Favorite Biotech Stocks Under $10 - Seeking Alpha
- 5 days ago - Moderna, Inc. (MRNA) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum Transcript - Seeking Alpha
- 6 days ago - Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK - Accesswire
- 6 days ago - Moderna: Maintaining Sell Despite Consolidation - And Why MRNY Won't Help Either - Seeking Alpha
- 7 days ago - Moderna's COVID-19 Vaccine Update Boosts Antibodies 16-Fold, Data Shows - Benzinga
- 7 days ago - Moderna's (MRNA) New COVID-19 Vaccine Shows Promising Results in Phase 4 Trial - GuruFocus
- 7 days ago - Moderna (MRNA) Shows Promising Results with New COVID-19 Vaccine Formula - GuruFocus
- 7 days ago - Moderna updates late-stage trial data for redesigned COVID shot - Seeking Alpha